Skip to main content
. 2019 Aug 26;52(3):302–311. doi: 10.5115/acb.18.180

Table 1. Changes in body weights, liver weights, liver indices, and total scores gained based on the severity of liver pathology among experimental groups.

C FA V CEO10 CEO20 CEO100
Primary body weight (g) 255.50±23.43 251.62±16.81 251.87±15.08 254.75±27.88 253.62±22.60 253.75±25.08
Final body weight (g) 294.37±12.53 230.75±16.49a) 233.75±21.71a) 239.87±17.62a) 243.87±21.75a) 284.75±23.10e)
∆Weight (g) 41.87±17.38 −0.25±6.90a) −0.12±3.97a) 3.37±7.40a) 10.62±3.70a) 35.50±18.52e)
Liver weight (g) 5.73±0.31 7.07±0.55a) 7.05±0.38a) 6.66±0.40c) 6.42±0.58 6.01±0.65f)
Liver index 1.93±0.19 2.83±0.37a) 2.81±0.24a) 2.59±0.21b) 2.43±0.22d,g) 2.08±0.28e)
Scoreh)
 Fatty degeneration 0 0 0 0 0 0
 Cell swelling 0 3 3 3 2 2
 Inflammation 0 4 4 3 3 1
 Necrosis 0 4 4 4 2 1
 Total scores 0 11 11 10 7 4

Values are expressed as mean±SD. C, control; FA, formaldehyde 10 mg/kg; V, FA 10 mg/kg+solvent; CEO10,20,100, FA 10 mg/kg+cinnamon essential oil 10, 20, 100 mg/kg. a)P<0.0001 when compared to control. b)P<0.001 when compared to control. c)P<0.01 when compared to control. d)P<0.05 when compared to control. e)P<0.0001 when compared to formaldehyde. f)P<0.01 when compared to formaldehyde. g)P<0.05 when compared to formaldehyde). h)Scores used to evaluate the liver pathology was as follows: score 0, no visible cell damage; score 1, focal hepatocyte damage on less than 25% of tissue; score 2, focal hepatocyte damage on 25%–50% of tissue; score 3, extensive but focal hepatocyte lesions; score 4, global hepatocyte necrosis.